Mullet, I'm not talking about Poly getting P2b ABSSSI trials going, or even Oral Mucositis trials started. I'm saying it would be difficult, if not impossible, for them to take on additional research into treatments for CRE or other infectious diseases until they either find a suitable partner or start getting a lot more funding.
I keep seeing posts here and on Yahoo! about this or that disease becoming near-epidemic or developing resistance to traditional antibiotics. Since they are posted on Poly's forums, the conclusion most would make is that those are conditions ripe for Poly's "magic". While I agree that Poly's pipeline could likely cure many infectious diseases, the company just won't have the ability to do anything about them barring massive new funding or the government declaring an emergency (and providing... you guessed it, massive new funding).
